Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. SANDOZ INC. (D.N.J. 2024)
✉ Email this page to a colleague
ASTRAZENECA PHARMACEUTICALS LP v. SANDOZ INC. (D.N.J. 2024)
| Docket | 3:24-cv-00641 | Date Filed | 2024-02-02 |
| Court | District Court, D. New Jersey | Date Terminated | 2026-04-28 |
| Cause | 35:271 Patent Infringement | Assigned To | Jennifer Choe-Groves |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 11,633,396; 7,449,464; 8,475,842; 8,859,562 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. SANDOZ INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , and ⤷ Start Trial .
Details for ASTRAZENECA PHARMACEUTICALS LP v. SANDOZ INC. (D.N.J. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-02-02 | External link to document | |||
| 2024-02-02 | 1 | Exhibit B (842 patent) | O11085.6 A1 2, 2001 7,449,464 B2 11/2008 Martin et al. … (464 patent), # 2 Exhibit B (842 patent), # 3 Exhibit C (396 patent), # 4 Exhibit D (562 patent), # 5…United States Patent (10) Patent No.: … (45) Date of Patent: Jul. 2, 2013 (54) IMMEDIATE…6,514,983 B1 2/2003 Li et al. patent is extended or adjusted under 35 | External link to document |
| 2024-02-02 | 12 | Text of Proposed Order | Filed 03/19/24 Page 2 of 3 PageID: 310 Patent Nos. 7,449,464 and 8,859,562), and the same active ingredient…and involve the same Plaintiffs, two of the same patents (U.S. … 2 February 2024 3:24-cv-00641 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2024-02-02 | 13 | Order AND ~Util - Create Case Association AND ~Util - Set/Clear Flags | Filed 03/27/24 Page 2 of 3 PageID: 313 Patent Nos. 7,449,464 and 8,859,562), and the same active ingredient…and involve the same Plaintiffs, two of the same patents (U.S. … 2 February 2024 3:24-cv-00641 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2024-02-02 | 14 | Answer to Complaint AND Counterclaim | .S. Patent No. 7,449,464 (“’464 patent”), U.S. Patent No. 8,475,842 (“’842 patent”), U.S. Patent No. ….S. Patent No. 7,449,464 (“’464 patent”), U.S. Patent No. 8,475,842 (“’842 patent”), U.S. Patent No.…of U.S. Patent No. 7,449,464 (“the ’464 patent”); U.S. Patent No. 8,475,842 (“the ’842 patent”); U.S. …. Patent No. 8,859,562 (“the ’562 patent”); and U.S. Patent No. 11,633,396 (“the ’396 patent”). These …8,859,562 (“’562 patent”), and U.S. Patent No. 11,633,396 (“’396 patent”) (collectively, “Patents-in-Suit”) | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
